“…Endometrial stromal ASCs were also shown to be capable of multi-lineage differentiation into fat, bone (confirmed with presence of osteopontin, ostenectin and alkaline phosphatase) [ 22 ], cartilage, skeletal muscle [ 23 , 24 ], and smooth muscle (expressing specific smooth muscle cell markers including alpha-smooth muscle actin (α-SMA), desmin, vinculin and calponin) [ 25 ]. Plasticity has also been shown by the trans-differentiation of endometrial stromal ASCs into neural (neural and glial lineage markers such as Nestin, NF-L, MAP2, PDGFRa, CNP, Olig2, MBP and GFAP) [ 24 , 26 ], Schwann cells (expression of S100 and P75 noted) [ 27 ], Oligodendrocytes [ 28 ], pancreatic cells (shown by secretion of insulin and markers of β cells such as PDX1, proinsulin and c-peptide) [ 29 , 30 ], urinary bladder epithelial cells (urothelium, as tested by urothelium-specific genes and proteins, uroplakin-Ia/Ib, II, III and cytokeratin 20) [ 31 ], hepatocytes (biomarkers albumin and cytokeratin 8, reduced α-fetoprotein and α-SMA expression, synthesised urea, and stored glycogen) [ 32 , 33 ], and megakaryocytes (identified by expression of CD41a and CD42b and reduction of pluripotent transcription factors Oct4 and Sox2, platelets were seen as functional as evidenced by the upregulation of CD62p expression and fibrinogen binding following thrombin stimulation), both in vitro and in animal models [ 34 , 35 ].…”